These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16911905)
1. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. Stevenson LW; Desai AS J Card Fail; 2006 Aug; 12(6):407-12. PubMed ID: 16911905 [TBL] [Abstract][Full Text] [Related]
2. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
4. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
5. Patient selection for primary prevention ICDs--are eps shocking patients into consent? Saxon LA J Card Fail; 2006 Aug; 12(6):413-5. PubMed ID: 16911906 [No Abstract] [Full Text] [Related]
6. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator. Krahn AD; Hoch JS; Rockx MA; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ Am J Cardiol; 2008 Sep; 102(5):588-92. PubMed ID: 18721517 [TBL] [Abstract][Full Text] [Related]
7. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Das M Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214 [TBL] [Abstract][Full Text] [Related]
8. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]
9. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
10. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717 [TBL] [Abstract][Full Text] [Related]
11. Implanted cardioverter defibrillators for the prevention of sudden death. Dorian P; Talajic M; Tang A Can J Cardiol; 2005 May; 21 Suppl A():31A-36A. PubMed ID: 15953942 [TBL] [Abstract][Full Text] [Related]
12. Use of beta-blockers in patients with an implantable cardioverter defibrillator. LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655 [TBL] [Abstract][Full Text] [Related]
13. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Ding L; Hua W; Niu H; Chen K; Zhang S Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death. Boriani G; Gasparini M; Lunati M; Santini M; Landolina M; Vincenti A; Curnis A; Bocchiardo M; Padeletti L; Biffi M; Allaria L; Denaro A; Am Heart J; 2006 Sep; 152(3):527.e1-11. PubMed ID: 16923425 [TBL] [Abstract][Full Text] [Related]
16. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003 [TBL] [Abstract][Full Text] [Related]
17. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Klein MH; Gold MR Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188 [TBL] [Abstract][Full Text] [Related]
18. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system. Gillis AM Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941 [TBL] [Abstract][Full Text] [Related]
19. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center. Bradfield J; Warner A; Bersohn MM Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S194-7. PubMed ID: 19250092 [TBL] [Abstract][Full Text] [Related]